Stevanato Group S.p.A. (NYSE:STVN) Receives Consensus Rating of "Moderate Buy" from Analysts

Key Points

• Stevanato Group has a “Moderate Buy” consensus rating from seven analysts: three rate it a hold, two recommend buying, and two assign a strong-buy rating. UBS initiated coverage with a neutral rating and a €23 price target, while TD Cowen upgraded the stock to strong buy.
• The company reported quarterly revenue of €302 million and EPS of €0.14, slightly below the €0.15 analyst consensus. Analysts expect full-year EPS of €0.69.
• Several institutional investors recently established or increased positions, while insiders sold shares primarily to cover tax obligations tied to equity awards. The stock opened at €20.96, with a market capitalization of approximately $6.35 billion.

Stevanato Group S.p.A. (NYSE:STVN - Get Free Report) has earned a consensus rating of "Moderate Buy" from the seven ratings firms that are presently covering the company, MarketBeat.com reports. Three research analysts have rated the stock with a hold recommendation, two have assigned a buy recommendation and two have assigned a strong buy recommendation to the company.

Several equities analysts have recently weighed in on the stock. TD Cowen raised shares of Stevanato Group to a "strong-buy" rating in a report on Wednesday, June 17th. Weiss Ratings raised shares of Stevanato Group from a "hold (c-)" rating to a "hold (c)" rating in a report on Thursday, August 27th. Finally, UBS Group initiated coverage on shares of Stevanato Group in a research report on Wednesday, September 9th. They set a "neutral" rating and a $23.00 price target on the stock.

Stevanato Group Stock Down 0.1%

Stevanato Group stock opened at €20.96 on Thursday. The firm has a market cap of $6.35 billion, a price-to-earnings ratio of 37.42, a price-to-earnings-growth ratio of 1.73 and a beta of 0.75. Stevanato Group has a 52 week low of €12.89 and a 52 week high of €27.99. The business's 50-day moving average price is €21.09 and its 200 day moving average price is €18.41. The company has a quick ratio of 1.08, a current ratio of 1.61 and a debt-to-equity ratio of 0.21.

Stevanato Group (NYSE:STVN - Get Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The company reported €0.14 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of €0.15 by (€0.01). Stevanato Group had a net margin of 10.99% and a return on equity of 10.43%. The company had revenue of €302.00 million during the quarter. As a group, sell-side analysts anticipate that Stevanato Group will post 0.69 earnings per share for the current year.

Insiders Place Their Bets

In related news, CFO Marco Dal Lago sold 4,209 shares of the company's stock in a transaction dated Friday, August 7th. The stock was sold at an average price of €20.09, for a total value of €84,558.81. Following the completion of the transaction, the chief financial officer owned 81,144 shares of the company's stock, valued at approximately €1,630,182.96. This represents a 4.93% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Luciano Santel sold 2,023 shares of the stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of €20.09, for a total value of €40,642.07. Following the transaction, the director owned 4,739 shares in the company, valued at €95,206.51. This represents a 29.92% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 21,926 shares of company stock worth $459,738 in the last 90 days. 0.70% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in the business. Wellington Management Group LLP acquired a new position in Stevanato Group in the 2nd quarter valued at $22,621,000. Ranger Investment Management L.P. acquired a new stake in Stevanato Group during the 2nd quarter worth $21,438,000. Conestoga Capital Advisors LLC boosted its stake in Stevanato Group by 7.6% during the 1st quarter. Conestoga Capital Advisors LLC now owns 8,491,751 shares of the company's stock worth $116,762,000 after purchasing an additional 602,050 shares during the last quarter. Confluence Investment Management LLC purchased a new stake in shares of Stevanato Group during the second quarter worth $6,062,000. Finally, Roubaix Capital LLC grew its holdings in shares of Stevanato Group by 96.6% during the first quarter. Roubaix Capital LLC now owns 385,316 shares of the company's stock worth $5,298,000 after buying an additional 189,343 shares in the last quarter.

About Stevanato Group

Stevanato Group S.p.A. is an Italy-based provider of drug-containment, drug-delivery and diagnostic solutions for the pharmaceutical, biotechnology and healthcare industries. The company serves customers across the development, production and administration of injectable medicines, with activities spanning pharmaceutical glass packaging, medical devices and manufacturing technologies.

Its product portfolio includes glass vials, cartridges, syringes and other primary containers, as well as ready-to-use packaging solutions such as EZ-fill.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.